20.05
price down icon3.79%   -0.79
after-market Dopo l'orario di chiusura: 20.45 0.40 +2.00%
loading
Precedente Chiudi:
$20.84
Aprire:
$20.76
Volume 24 ore:
275.24K
Relative Volume:
3.08
Capitalizzazione di mercato:
$1.26B
Reddito:
-
Utile/perdita netta:
$-143.59M
Rapporto P/E:
-7.1009
EPS:
-2.8236
Flusso di cassa netto:
$-119.47M
1 W Prestazione:
-15.51%
1M Prestazione:
+16.57%
6M Prestazione:
+6.99%
1 anno Prestazione:
+12.26%
Intervallo 1D:
Value
$20.05
$21.30
Intervallo di 1 settimana:
Value
$20.05
$24.05
Portata 52W:
Value
$11.51
$26.33

Pharvaris Nv Stock (PHVS) Company Profile

Name
Nome
Pharvaris Nv
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
119
Name
Cinguettio
Name
Prossima data di guadagno
2025-07-25
Name
Ultimi documenti SEC
Name
PHVS's Discussions on Twitter

Confronta PHVS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
PHVS
Pharvaris Nv
20.05 1.26B 0 -143.59M -119.47M -2.8236
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Pharvaris Nv Stock (PHVS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-11 Iniziato Guggenheim Buy
2025-04-29 Iniziato Cantor Fitzgerald Overweight
2023-09-25 Iniziato Wedbush Outperform
2023-08-15 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2022-10-05 Iniziato Bryan Garnier Buy
2022-09-13 Ripresa JMP Securities Mkt Outperform
2022-08-23 Downgrade Morgan Stanley Overweight → Equal-Weight
2022-08-22 Downgrade BofA Securities Neutral → Underperform
2022-05-25 Iniziato JMP Securities Mkt Outperform
2021-03-02 Iniziato BofA Securities Neutral
2021-03-02 Iniziato Morgan Stanley Overweight
2021-03-02 Iniziato Oppenheimer Outperform
2021-03-02 Iniziato SVB Leerink Outperform
Mostra tutto

Pharvaris Nv Borsa (PHVS) Ultime notizie

pulisher
Jul 24, 2025

How Pharvaris N.V. stock reacts to Fed policy changesRapidly growing investment returns - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Pharvaris Raises $201 Million in Successful Offering - TipRanks

Jul 24, 2025
pulisher
Jul 24, 2025

Pharvaris Announces Closing of $201.2 Million Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares - Stock Titan

Jul 24, 2025
pulisher
Jul 23, 2025

Is Pharvaris N.V. a good long term investmentRapid growth opportunities - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Pharvaris: Deucrictibant Advanced To Target Two Sets Of HAE Patient Populations (PHVS) - Seeking Alpha

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Pharvaris N.V. stock priceHigh-yield capital appreciation - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Pharvaris shares slide following $175 million equity offering - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

Pharvaris stock drops after pricing $175 million public offering By Investing.com - Investing.com Nigeria

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Pharvaris N.V. stockOutstanding growth strategies - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Pharvaris' $175M Equity Raise: A Strategic Catalyst for HAE Market Leadership - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

Pharvaris N.V. Stock Analysis and ForecastExponential return rates - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Pharvaris' $175M Equity Raise: Fueling a Strategic Leap in the HAE Market - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

Pharvaris prices $175 million public offering to fund angioedema programs By Investing.com - Investing.com India

Jul 22, 2025
pulisher
Jul 22, 2025

Pharvaris Announces Pricing of Upsized $175 Million Public Offering of Ordinary Shares and Pre-Funded Warrants - The Manila Times

Jul 22, 2025
pulisher
Jul 22, 2025

Pharvaris prices $175 million public offering to fund angioedema programs - Investing.com

Jul 22, 2025
pulisher
Jul 22, 2025

Pharvaris Secures Massive $175M Public Offering to Advance Oral HAE Treatment Pipeline - Stock Titan

Jul 22, 2025
pulisher
Jul 22, 2025

Pharvaris Announces Pricing of Upsized $175 Million Public Offering of Ordinary Shares and Pre-Funded Warrants - GlobeNewswire Inc.

Jul 22, 2025
pulisher
Jul 22, 2025

Pharvaris' $150M Share Offering: Balancing Dilution Risk and HAE Market Capture in a High-Margin Niche - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

IKNA issues special CVR dividend ahead of Inmagene merger | PHVS SEC FilingForm 424B5 - Stock Titan

Jul 22, 2025
pulisher
Jul 22, 2025

Pharvaris announces $150M ordinary shares offering - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

Pharvaris Announces Proposed Public Offering of Ordinary Shares - The Manila Times

Jul 22, 2025
pulisher
Jul 22, 2025

Pharvaris Seeks $150M in Public Offering: Major Push for Late-Stage HAE Drug Development - Stock Titan

Jul 22, 2025
pulisher
Jul 21, 2025

Understanding Stock Volatility in the Indian Market AI Driven Stock AlertsFree Risk Assessment Services - Autocar Professional

Jul 21, 2025
pulisher
Jul 20, 2025

Property Share Investment Trust (544295) Hits 52 Week HighRapid wealth creation - Autocar Professional

Jul 20, 2025
pulisher
Jul 20, 2025

What drives PTON stock priceBreakout stock performance - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 19, 2025

What drives iShares Gold Trust stock priceHigh-yield capital appreciation - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

NSE Quality Stocks Smart Investor Club PicksHigh-velocity gains - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

Best Renewable Stocks Smart Money Stock PicksPowerful growth strategies - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

What risks could impact Pharvaris N.V. stock performanceHigh Return Stock Alerts - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Pharvaris: More Convenience, More Potency, And More Potential For Future HAE Success - Seeking Alpha

Jul 18, 2025
pulisher
Jul 17, 2025

How To Trade (PHVS) - news.stocktradersdaily.com

Jul 17, 2025
pulisher
Jul 16, 2025

Why Pharvaris N.V. stock attracts strong analyst attentionGrowth Optimized Stock Radar - beatles.ru

Jul 16, 2025
pulisher
Jul 15, 2025

How Pharvaris N.V. stock performs during market volatilityFree Investment Community - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Pharvaris N.V. stock price move sharplyReal Time Alert Service - Newser

Jul 15, 2025

Pharvaris Nv Azioni (PHVS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):